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Abstract
Purpose: The counseling regarding the treatment option is an important objective in the management of early stages breast
cancer. The purpose of this study is to present a comparison between the dosimetric aspects of 3DCRT and IMRT in the whole
breast radiotherapy. Methods: Both right and left sided computed tomography simulations of 14 women with early stage breast
cancer were used for our retrospective study to compare the 3DCRT and IMRT. The dose prescribed was 50 Gray (Gy) in 25
fractions to the whole breast PTV. The PTV was defined by adding unequal margins to the directional safety margin status of
each lumpectomy cavity (i.e., medial, lateral, superior, inferior and deep margins measured from the tumor front after the ex-
amination of the surgical specimen: 2, 1.5, and 1 cm for resection margins < 1 cm, 1-2 cm, and > 2cm, respectively) and then
modified so that it was no longer closer than 3 mm to the skin surface and was no deep than the lung –chest interface. The pre-
scribed dose delivered in 5 fractions per week schedule. Treatment plans were compared for target minimum dose, maximum
dose, mean dose, conformity index, heterogeneity index and doses to organs at risk were compared and analyzed. Results: The
target coverage was achieved with 90% prescription to the 95% volume of the PTV. Conformity to the PTV was significantly
higher with 3DCRT technique than IMRT. 3DCRT technique seems better in sparing critical organs parameters like lung V20
and Mean, heart, V25, Maximum, both lungs V20, Mean and Dose to the Normal Healthy tissue. Conclusion: We conclude from
our study that treatment technique selection for whole Breast irradiation is an important factor in sparing the adjacent normal
structures and in determining the associated risk. 3DCRT produces better conformity and heterogeneity indices of the target
volume, also reduces dose to OARs and reduces the risk of radiation induced heart diseases.
Keywords:Whole Breast Irradiation; Planning Tumor Volume; Organs at Risk; Conformity Index; Heterogeneity Index; Breast
Conservative Surgery
Introduction
An estimated 12.66 million people were diagnosed with
cancer across the world in 2008, and 7.56 million people died
from the disease. Just four cancer sites lung, female breast,
colorectal and stomach accounted for two-fifths of the total
cases diagnosed worldwide. Breast cancer is the most com-
mon cancer in females worldwide. As per World Health
Organization (WHO) estimate, in Bahrain the incidence of
breast cancer was 116.47 per 100,000 in 2008. Unlike other
cancers, breast cancer is successfully treatable if detected at
an early stage.1
The incidence of breast cancer has increased globally over
the last several decades.2, 3, 4 The greatest increase has been in
Asian countries.5 In Asia, breast cancer incidence peaks
among women in their forties whereas in the United States
and Europe, it peaks among women in their sixties. In India
premenopausal patients constitute about 50% of all patients.6
It is expected that in the coming decades, these countries
would account for majority of new breast cancer patients
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diagnosed globally. Over 100,000 new breast cancer patients
are estimated to be diagnosed annually in India.7
Radiotherapy is an integral part of breast cancer management
after Breast Conservative Surgery (BCS) in early stage breast
cancer. Survival rates are similar for BCS with adjuvant Ra-
diotherapy (RT) and mastectomy for early stage breast cancer
and Breast Conservative Surgery (BCS) is known as a gold
standard.8, 9, 10 Whole breast irradiation is the commonest
method of management for early breast cancer treatment
after BCS. The greatest challenge for radiation therapy or
any cancer therapy is to attain the highest probability of cure
with the least morbidity. The simplest way in theory to in-
crease this therapeutic ratio with radiation is to encompass
all cancer cells with sufficient doses of radiation during each
fraction, while simultaneously sparing surrounding normal
tissues. In practice, however, we have been hampered by our
abilities to both identify the cancer cells and target them
with radiation. The modern radiotherapy has evolved from
non-site-specific techniques using bony anatomy and
hand-drawn blocking toward specialized planning incorpo-
rating three-dimensional reconstructions of images and
computer optimization algorithms. Corresponding to these
changes, there has been specialization in the types of tech-
nology used for different cancer sites. Two-dimensional (2D)
radiotherapy consisted of a single beam from one to four
directions. Beam setups were usually quite simple; plans
frequently consisted of opposed lateral fields or four field
“boxes”. Three-dimensional (3D), or Computed Tomography
(CT) based, planning was a major advance because it took
into account axial anatomy and complex tissue contours and
while 3D planning allows for accurate dose calculations to
such irregular shapes, we are still limited in the corrections
we could make. The intensity-modulated radiation therapy
(IMRT) allows us to modulate the intensity of each radiation
beam, so each field may have one or many areas of high in-
tensity radiation and any number of lower intensity areas
within the same field, thus allowing for greater control of
the dose distribution with the target. By modulating both the
number of fields and the intensity of radiation within each
field, we have limitless possibilities to sculpt radiation dose.
Advanced treatment planning software has furthered our
ability to modulate radiation dose. Instead of the clinician
choosing every beam angle and weighting, computer opti-
mization techniques can now help determine the distribu-
tion of beam intensities across a treatment volume, which
often include a non-intuitive distribution of “beamlets,” or
1-cm2 areas of isointensity.11
There are various methods to employ radiotherapy for breast
cancer in women. Conventionally tangential fields are em-
ployed to treat the whole breast. With the recent advances in
treatment planning technology and Multi Leaf Collimators
(MLC), Three Dimensional Conformal Radiotherapy
(3DCRT) is widely used for treatment of breast carcinoma.
Conformal therapy reduces normal tissue doses and increases
conformity to target volume. With the advent of advanced
sophisticated treatment planning software intensity modu-
lated radiation therapy is becoming increasingly popular.
The aim of our study is to compare three dimensional con-
formal radiation therapy (3DCRT) versus intensity modulated
radiation therapy (IMRT) planning based on standard plan
indices using Computerized Medical Systems (CMS) Xio
(4.70.02 version, ELEKTA) treatment planning system.
Methods and Materials
CT Imaging
This study is conducted using treatment plans done on the
Computed Tomography (CT) simulation data sets (2.5 mm
slice thickness) of 14 consecutive patients (7 right sided breast
carcinoma, 7 left sided breast carcinoma) with T1 or T2 axil-
lary node negative invasive carcinoma of breast for our ret-
rospective analysis. The Planning Tumor Volume (PTV) size
varied from 855.73 cm3 to 1347 cm3 with a mean value of
1025.35 cm3. These patients were already treated with IMRT.
Radiation Therapy was started within three weeks after the
breast conservation surgery consisting of removal of primary
tumor with a margin referred as lumpectomy or segmental
mastectomy and chemotherapy. A radio opaque wire was
placed around the ipsilateral breast by Radiation Oncologist
to define the treatment ports for the PTV. The same CT data
sets target volumes and organs at risk volumes were used for
3DCRT study.
Target and organ at risk delineation
After planning CT was done, the Digital Imaging and Com-
munication in Medicine (DICOM) images were transferred to
CMS Xio (4.70.02 version, ELEKTA) treatment planning
system. The contours that were generated were the Gross
Tumor Volume (GTV), Clinical Tumor Volume (CTV),
Planning Target Volume (PTV), ipsilateral lung, contralateral
lung, contralateral breast, heart, spinal cord and body. The
GTV which is the gross tumor volume is the total lumpec-
tomy cavity which can be identified with the help of surgical
clips placed at the time of surgery. The CTV was defined by
the three dimensional uniform 1.5 cm margin expanded in all
directions around the GTV, however this volume was con-
strained to lie 5 mm within the external contour and up
against the major muscle. The PTV volume was defined to lie
within the radio-opaque wire kept during CT simulation as
deep as the anterior chest wall muscles. The lungs and ex-
ternal surfaces contoured using semi-automatic contouring
techniques. The CTV, PTV, and Organs at Risk (OARs) were
generated in accordance with the Radiation Therapy Oncol-
ogy Group (RTOG) 0319 protocol.12
Treatment Planning Details and Dose Prescription
All treatment plans were generated with 6 MV (Mega volt-
age) photon beams to maintain the comparison between the
two treatment techniques. Treatment plans were done using
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CMS Xio (4.70.02 version, ELEKTA) for IMRT treatment and
3DCRT treatment.
The treatment fields were almost evenly placed within an arc
of 180 degree swept by the gantry. The gantry angles ranged
from 300 to 160 (clockwise) for left side tumors and from 60
to 210 (counter clockwise) for right side tumors were chosen
to create optimum IMRT plans. The dose prescribed to the
Breast volume (PTV) was 50 Grays (Gy) in 25 fractions (2.0
Gy/fraction). The dose uniformity and conformity were cal-
culated and evaluated.
The Conformity Index (CI) as defined in the International
Commission of Radiological Units (ICRU) report 83 is( ) = ℎ
C.I = 1.0 (one) is the ideal value.
The Homogeneity Index (HI) as defined in ICRU report 83 is=
H.I = 1(one) is the ideal value.
Where, D5%, D95%, D50% is the dose received by 5%, 95%, 50%
volume.
3DCRT Planning
Two opposite tangential beams were constructed to conform
to whole breast PTV. A margin of 1 cm between the MLC
and PTV was set for coverage. Using Beam’s Eye View (BEV)
fields were set up to minimize the dose to heart, left de-
scending coronary artery (LAD), contralateral breasts and
ipsilateral lung and maximize the target coverage. The “iso-
center” of the treatment machine was positioned at the cen-
ter of the midline joining the two parallel opposite fields.
The plans were created for 3DCRT, in which tangential co-
planar beams were used to produce adequate dose coverage
for Planning Target Volume (PTV). Critical organs were
shielded using MLC without compromising with the PTV
coverage. Beam weights were adjusted until the optimum
coverage and acceptable hot spots were achieved. The PTV
was set to receive 95% of the prescribed dose. Also, hot spot
volumes blocking subfields were determined to achieve the
better dose homogeneity and to avoid the overdose in the
PTV.  By viewing the 105% dose cloud in a beam’s eye view
projection of the treatment fields, subfields were designed by
blocking the volume of PTV receiving greater than 105% of
the prescribed dose to boost the low dose volume of the PTV
(volume of the PTV receiving less the 95% of the prescribed
dose) by delivering 5 to 10 monitor units. The shape of the
subfield was iteratively modified with aided visualization of
105% dose cloud in the beam’s eye view. The main field and
subfields were merged into one portal.
IMRT Planning
TABLE 1: Dose constraints for 3DCRT and IMRT planning.
Organ Parameter Dose
(cGy)
Volume (%)
PTV Maximum
Dose
5500 0
Minimum
Dose
4700 100
Ipsilateral Lung Mean Dose 2000 30
Contralateral
Lung
Mean Dose 2000 33% volume of
(Lung-PTV)
Contralateral
Breast
Mean Dose 1500 5%
Heart Mean Dose 3500 0
Point Dose 500 Less than the Pre-
scribed dose
In this technique, the fluence based step and shoot IMRT
optimized plans were generated to achieve the same objec-
tives described for the 3DCRT plans, the number of beam
segments was not restricted during optimization and no at-
tempts have been made for beam angle optimization as CMS
Xio does not support beam angle optimization. The PTV for
IMRT was the same as used for the 3DCRT plans plus an
extension into the air anterior of the PTV of 1.5 cm in order
to compensate the set up uncertainties and up and down
movement of the chest due to respiration. The dose was pre-
scribed to the PTV and the dose constraints presented in the
Table 1 were set to the treatment planning system. Tissue
heterogeneity was considered in the treatment planning
optimization process and the dose calculation was done by
using superposition/ convolution algorithm.
The CMS Xio (4.70.02 version, ELEKTA) treatment planning
system Dose Volume Histogram (DVH) window was used to
analyze the PTV’s mean, maximum and minimum doses and
for OAR’s mean, maximum, minimum doses, percentage of
volume receiving 3000cGy (V30), percentage of volume re-
ceiving 2000 cGy (V20), percentage of volume receiving 1000
cGy (V10), and isodose volumes for 50%, 30% and 10%. Also
to illustrate the low dose volume effects, Dose Volume His-
togram for normal healthy tissue are also incorporated and
Monitor Units (MU) were also noted in order to access and
understand integral dose (ID) contribution, the Monitor
Units (MU) for both the plans were noted and taken for
analysis. The more monitor unit signifies the more integral
dose. The integral dose ID to an organ j divided into m
voxels is given by the following equation:13=
Where, Vkj, DKJ and Pkl are respectively the volume, dose and
density of voxel k in organ j. If the voxels have all the same
size and the organ can be assumed to have a uniform density,
the integral dose equation can be reduced to =
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Statistical Analysis
For qualitative analysis of the two techniques, a very suitable
method of investigation is provided by Wilcxon’s Signed
Rank sum test, which operates as follows. First, put all the
observations in ascending order of their magnitude, ignoring
the signs. Any zero values are ignored and the remaining
non-zero values are assigned rank 1 to n. If any of the obser-
vations are numerically equal they are each assigned an av-
erage rank calculated from the rank that would otherwise
have been used. Such ranks are said to be tied. Next calculate
the sum of the ranks of the positive observations and refer
the table for appropriate significance level.14
The above said statistical analysis was performed for qualita-
tive ranking of the two techniques using Statistical Package
for Social Sciences (SPSS) version12.0 (SPSS Inc., Chicago,
USA) software. This matched pair t-test was applied to de-
termine the statistical difference between the dose volume
data for IMRT versus 3DCRT. The reported p-value is two
tailed and p-values of < 0.05 are considered significant or else
non-significant (NS).
Results
TABLE 2: (a) Comparison of average dosimetric characteristics for
left Whole Breast PTV for IMRT and 3DCRT technique. (Prescribed
dose 5,000 cGy in 25 fractions).
Dosimetric Parameter IMRT 3DCRT p-Value
Max Dose (cGy) 5594.34 5606.43 0.055*
Min Dose (cGy) 2249.47 1714.17 0.039
Mean Dose (cGy) 4984.34 5041.63 0.031
95% volume 4567.4 4565.24 0.063*
Conformity Index 0.90 0.89 0.063*
Heterogeneity Index 1.16 1.14 0.023
Monitor Unit (MU) 761.4 260.6 0.008
*= statistically insignificant
TABLE 2: (b) Comparison of average dosimetric characteristics for
right Whole Breast PTV for IMRT and 3DCRT technique. (Pre-
scribed dose 5,000 cGy in 25 fractions).
Dosimetric Parameter IMRT 3DCRT p-Value
Max Dose (cGy) 5618.96 5565.96 0.063*
Min Dose (cGy) 2842.13 1171.70 0.008
Mean Dose (cGy) 4945.33 5172.94 0.039
95% volume 4537.56 4681.44 0.016
Conformity Index 0.94 0.95 0.125*
Heterogeneity Index 1.12 1.10 0.024
Monitor Unit (MU) 2502 1297.4 0.008
*= statistically insignificant
The treatment plans were optimized to meet the planning
objectives in both the treatment techniques and to achieve
the prescribed dose delivery for more than 90% of the pre-
scribed isodose to encompass greater than 95% of the PTV
volume. The PTV size varied from 855.73 cm3 to 1347 cm3
with a mean value of 1025±35 cm3. In 3DCRT, 105% dose
(hot spots) was observed in less than 5% of the target volume.
The normalized target coverage for IMRT and 3DCRT in PTV
and for both classes of the patients were presented in the
Table 2a and 2b. Figure 1 demonstrates the dose distribution
in axial sections for the two classes of patients (right sided
diseases patient and left sided disease patient) for IMRT and
3DCRT plans of the same patient. The axial sections clearly
depict the concave target PTV coverage and in all left sided
breast patients, the left anterior descending coronary artery
(LAD) is little away from the PTV and not receiving any
significant dose in both the techniques.
(a)
(b)
(c)
(d)
FIG. 1: Represents the 20 Gy volume of dose color wash in 3DCRT (a,
b) and IMRT (c, d) breast plans.
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The comparison and dosimetric analysis for the Planning
Target volume (PTV) presented in the Table 2a, 2b depicts
that there is no significant difference in maximum dose and
conformity index in both the treatment techniques. Howev-
er, the heterogeneity index was found to be 1.16 for IMRT
and 1.14 for 3DCRT (p = 0.023) in left breasts and 1.12 for
IMRT and 1.10 for 3DCRT (p = 0.024) in the right breasts. All
the dosimetric parameter calculated for the Planning Target
Volume (PTV) except mean dose has appreciably higher
values in IMRT plans than 3DCRT plans. Moreover, the do-
simetric analysis carried out for ipsilateral lung dose param-
eters like mean dose, V5, V10 were found to have higher values
in all IMRT plans than 3DCRT plans. The difference is pre-
sented in Table 3 for both classes of the patients.
TABLE 3: Comparison of mean values for ipsilateral lung parameters
for IMRT and 3DCRT in left sided breasts patients.
Dosimetric Parametric IMRT 3DCRT p-value
V5 (%) 57.70 24.76 0.008
V20 (%) 34.0 41.00 0.039
V30 (%) 26.94 32.65 0.031
V10 (%) 57.51 28.97 0.008
Mean Dose (cGy) 1377.96 1065 0.023
Figure 6 illustrates the Dose Volume Histogram (DVH) for
heart. A comparison of dosimetric parameters for heart is
presented in Table 4a, 4b. These parameters show much
higher values in IMRT technique than 3DCRT technique
except the dose value to the 33% of the heart volume and the
volume encompassed by 25% isodose line.
TABLE 4: (a) Comparison of mean values for heart dose parameters
for IMRT and 3DCRT in right sided breasts patients.
Dosimetric Parameter IMRT 3DCRT p-value
Max Dose (cGy) 3308.41 2315.05 0.039
Min Dose (cGy) 259.77 17.96 0.008
Mean Dose (cGy) 1198.1 149.84 0.047
33% Volume (cGy) 710.5 124.56 0.008
V25 (%) 2.34 1.80 0.055*
V10 (%) 20.72 2.95 0.016
*= statistically insignificant
TABLE 4: (b) Comparison of mean values for heart dose parameters
for IMRT and 3DCRT in left sided breasts patients.
Dosimetric Parameter IMRT 3DCRT p-value
Max Dose (cGy) 4699.99 4515.53 0.039
Min Dose (cGy) 330.30 50.57 0.008
Mean Dose (cGy) 1499.57 1184.24 0.008
33% Volume (cGy) 1035.84 1465.79 0.055*
V25 (%) 16.02 20.66 0.063*
V10 (%) 47.73 27.06 0.016
*= statistically insignificant
A comparison of average plan parameters for contralateral
breasts and both lungs is presented in Tables 5, and 6 respec-
tively. Dose Volume Histograms (DVHs) describing the dose
volume relation of the target as well as normal tissue for both
the techniques is presented in Figure 2-7. The mean value of
Monitor Units (MU) for left sided diseases in IMRT technique
was found to be 761.4 Monitor Units (MUs) as compared to
260.0 Monitor Units (MUs) in 3DCRT with (p = 0.008) and for
right sided diseases the average value of Monitor Units in
IMRT technique was observed to be 2502 Monitor Units
(MUs) compared to 1297.4 monitor units (MUs) in 3DCRT
(p = 0.008). The value of the monitor unit will depend on the
depth that we are going to treat. The higher value of MUs in
case of right sided breast disease may only because of large
breast volume or because of the pendulous breasts. Also, the
DVH shows considerably better normal tissue sparing with
3DCRT than IMRT for the intact whole breasts.
(a) DVH of PTV in IMRT and 3DCRT plans for right breast cancer
case
(b) DVH of PTV in IMRT and 3DCRT plans for left breast cancer case
FIG. 2: Cumulative dose volume histogram (DVH) of PTV comparing
3DCRT and IMRT plans for (a) right breast, and (b) left breast cancer
cases.
FIG. 3: Cumulative dose volume histogram (DVH) of ipsilateral lung
comparing 3DCRT and IMRT plans.
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FIG. 4: Cumulative dose volume histogram of both lungs comparing
3DCRT and IMRT plans.
FIG. 5: Cumulative dose volume histogram of contralateral breast
comparing 3DCRT and IMRT plans.
(a)DVH of heart in IMRT and 3DCRT plans for right breast cancer
case
(b) DVH of heart in IMRT and 3DCRT plans for left breast cancer
case. FIG. 6: Cumulative dose volume histogram of heart comparing
3DCRT and IMRT plans for (a) right breast cancer, and (b) left breast
cancer cases
(a) DVH of normal tissue in IMRT and 3DCRT plans for right breast
cancer case
(b)DVH of normal tissue in IMRT and 3DCRT plans for left breast
cancer case
FIG. 7: Cumulative dose volume histogram (DVH) of normal healthy
tissue comparing 3DCRT and IMRT plans for (a) right breast cancer,
and (b) left breast cancer cases.
TABLE 5: Comparison of mean values for contralateral Breast dose
parameters for IMRT and 3DCRT in right sided breasts patients.
Dosimetric parameter IMRT 3DCRT p-value
V5 (%) 12.065 8.30 0.031
Min Dose (cGy) 188.92 181.63 0.039
D5 (%) 737.38 786.2 0.027
Max Dose (cGy) 3861.00 4755.55 0.008
Mean Dose (cGy) 269.71 226.20 0.039
TABLE 6: Comparison of mean values for both lungs dose parame-
ters for IMRT and 3DCRT in left sided breasts patients.
Dosimetric Parametric IMRT 3DCRT p-value
V20 (%) 20.45 17.00 0.016
Mean Dose (cGy) 1892.17 778.69 0.016
Discussion
Several epidemiological studies have shown that in country
like India breast cancer patients usually come in advanced
stage of breast cancer, breast conservative surgery is not pos-
sible, so mastectomy is the treatment of choice and early stage
breast cancer is rare. In early stage breast cancer, breast con-
servative surgery is known as gold standard. There are dis-
tinct geometric differences between the target volume of the
chest wall and the whole breast, and these differences might
have an impact on the resulting dose distribution. In general,
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there is an optimum plan for every patient that treats the
breast tissue while sparing the organs at risk. However, the
technique one may use could vary depending on the patient
geometry and technology available in a particular radiother-
apy center. The number of studies has been carried out to
present the superiority of one technique over other. A very
recent study by Suresh Moorthy et al. 15 presents a Dosimetric
study of SIB-IMRT versus SIB-3DCRT for breast cancer with
breath-hold gated technique. The study envisages that in
comparison to 3DCRT, IMRT reduced the maximum dose to
the target volume, and dose to OAR was reduced too.
However, 3DCRT technique was superior in terms of low
dose volume of normal tissue, integral dose, and treatment
time. Consequences of these low doses would have to be
weighed against the benefits of reducing high doses on indi-
vidual patient selection basis. With the use of breath-hold
gated technique in IMRT, it can further improve the target
coverage and reduction of doses to the heart, lung, and LAD.
SIB technique could reduce the overall treatment duration
by about one week. The present study is intended to compare
the planning and dose delivery efficiency among two treat-
ment techniques of radiation therapy to the whole breast
namely three dimensional Conformal Radiotherapy (3DCRT)
and Intensity Modulated Radiotherapy (IMRT) in fair man-
ner for post lumpectomy breast cancer patients with CMS Xio
(4.70.02 version, ELEKTA) treatment planning system.
In this study tangential beam 3DCRT of the whole breast PTV
is compared to IMRT. Table 2 depicts that the IMRT results
are comparable to the 3DCRT technique in terms of the PTV
coverage, delivering 90% of the prescribed dose to greater
than 95% volume of the PTV, maximum dose delivered to the
whole breast PTV, and conformity index. The Monitor Units
in IMRT technique was higher than 3DCRT technique with p
– values 0.008. This envisages that the integral dose would be
higher probably due to multiple beams used in the IMRT
plans than tangentially oriented beams used in three dimen-
sional conformal plans to spare adjacent normal healthy tissue
structures. The leakage and scatter dose to the non-target
tissue is proportional to the number of Monitor Units used.
Some studies reported, increased low dose volumes with
increased number of beam angles increase the integral dose.16
In general, both IMRT and 3DCRT provided similar results
regarding the PTV coverage. But, in depth analysis of dosi-
metric data reveals significant difference in the quality of the
target coverage and normal tissue doses. For tangential beam
3DCRT technique the heterogeneity index for both left and
right sided breasts disease was nearer to the ideal value
compared to IMRT technique. While as, conformity indices
were found more or less equal. The 3DCRT technique reduces
the values for lung dose volume, heart dose volume, dose to
contralateral breast and dose to both lungs than IMRT tech-
nique without compromising the target coverage. In this
study, all most all the ipsilateral lung dose parameters were
observed to have higher values in IMRT technique than
3DCRT technique. The Radiation Induced Pneumonitis is
related to the ipsilateral lung volume irradiated, 17 the ipsi-
lateral lung V20 for IMRT (34.0%) is significantly less than
(41.00%) in 3DCRT (p = 0.039). Both lungs V20 parameters
have significantly lower values in 3DCRT technique than
IMRT with p – values 0.016. There is no absolute safe Mean
Lung Dose (MLD) below which there no Pneumonitis.18 The
clinically acceptable risk of radiation therapy depends on the
risk benefit ratio of the individual patient selection.
In patients with left sided breast cancer, it is intended that the
irradiated heart volume be minimized to the greatest possible
degree without compromising the target coverage as the risk
of pericardial events is probably related to both dose and
volume of irradiation. Stewart J R et al. 19 concludes that the
dose volume should be limited to 60 Gy for less than 20% of
the cardiac volume and 45 Gy for more than 65% of cardiac
volume. A very recent study on “Risk of Ischemic Heart
Diseases in Women after Radiotherapy for Breast Cancer” by
Sarah CD et al.20 suggests that the exposure of heart to ioniz-
ing radiations during radiotherapy for breast cancer increases
the subsequent rate of ischemic heart diseases. The increase is
proportional to the mean dose to heart, begins within few
years after exposure, and continues at least for 20 years.
Woman with preexisting cardiac risk factors have greater
absolute increase in risk from radiotherapy than other
women. Also, the rate of major coronary events increased
linearly with the mean dose to the heart by 7.4% per Gray,
with no apparent threshold. The risk starts within 5 years
after radiotherapy and continuous up to the third decade after
radiotherapy.
The IMRT plans contribute a modestly higher dose to adja-
cent healthy tissues. The main concern of with the healthy
soft tissue dose increases of such magnitude is an increased
risk of late secondary malignancy.21, 22
Conclusion
The objective of this study was to compare the dosimetric
characteristics of IMRT and 3DCRT techniques and to eval-
uate the characteristics of each modality when applied to the
whole breast radiotherapy in the early stage of the breast
cancer. The quality of the treatment plan dependence on the
many factors, in general, there is an optimum plan for every
patient that treats the breast tissue while sparing the organs at
risk. However, the technique one may use could vary de-
pending on the patient geometry and technology available in
a radiotherapy center such as treatment planning system
available, beam energy, TPS algorithm and the skills of the
planner as shown by Lu23, Rana24, and Pokharel.25
IMRT is now considered to be a mature radiotherapy tech-
nique and has become a frequently used modality in all most
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all the radiotherapy centers. The MLC-based IMRT technique
delivers non-uniform fluences to the patient from any given
position of the treatment beam to optimize the composite
dose distribution and to spare the adjacent organs at risk.
We infer from this study that treatment technique selection
for whole-breast irradiation is an important factor in sparing
the adjacent normal structures and in determining the asso-
ciated risk. 3DCRT reduces the dose to the OARs and in-
creases the heterogeneity index on CMS Xio (4.70.02 version,
ELEKTA) treatment planning system. Quantification of dose
to OARs may be useful for clinicians as they counsel women
with early stage breast cancer about their treatment option
Moreover, according to the Sarah CD et al. 19 recent study on
“Risk of Ischemic Heart Diseases in Women after Radio-
therapy for Breast Cancer”, the 3DCRT reduces the risk of
radiation induced heart diseases by a factor of about 9.62 in
right sided breast diseases than IMRT and by a factor of 1.27
in left sided breast diseases.
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